Validity and reliability of a point-of-care nerve conduction device in diabetes patients.
Diabetic polyneuropathy
Nerve conduction study
Point-of-care device
Journal
Journal of diabetes investigation
ISSN: 2040-1124
Titre abrégé: J Diabetes Investig
Pays: Japan
ID NLM: 101520702
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
30
07
2018
revised:
14
12
2018
accepted:
09
01
2019
pubmed:
20
1
2019
medline:
11
2
2020
entrez:
20
1
2019
Statut:
ppublish
Résumé
Although nerve conduction study (NCS) using a standard electromyography system (EMGS) is considered to be the gold standard in evaluating diabetic polyneuropathy, this examination requires expensive equipment and well-trained technicians. We aimed to validate a point-of-care device, NC-stat/DPNCheck™, that has been developed for widespread use of NCS in diabetic polyneuropathy. Diabetes patients underwent two kinds of NCS: DPNCheck™ and electromyography system. Inter-/intrarater reliability of DPNCheck™ were also determined by the intraclass correlation coefficient. A total of 57 patients were evaluated. The parameters of NCS between the two methods correlated well (r = 0.7734 for the sural nerve conduction velocity, r = 0.6155 for the amplitude of sural nerve action potential). The intraclass correlation coefficients were excellent (intrarater: the velocity 0.767, the amplitude 0.811; interrater: the velocity 0.974, the amplitude 0.834). The point-of-care device has excellent reproducibility and good agreement with standard electromyography system. The device might be useful to evaluate diabetic polyneuropathy.
Identifiants
pubmed: 30659760
doi: 10.1111/jdi.13007
pmc: PMC6717804
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1291-1298Subventions
Organisme : Fukuda Colin Company Limited
Informations de copyright
© 2019 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.
Références
J Diabetes Complications. 2017 Aug;31(8):1318-1324
pubmed: 28599823
Diabetes Res Clin Pract. 2007 Sep;77 Suppl 1:S178-83
pubmed: 17478005
Cancer Sci. 2016 Oct;107(10):1453-1457
pubmed: 27412083
J Diabetes Investig. 2019 Sep;10(5):1291-1298
pubmed: 30659760
J Diabetes Res. 2017;2017:1467213
pubmed: 29250555
Endocrine. 2014 Dec;47(3):690-8
pubmed: 24839196
J Clin Transl Endocrinol. 2017 Sep 20;10:9-14
pubmed: 29204366
IEEE Eng Med Biol Mag. 2010 Mar-Apr;29(2):26-36
pubmed: 20659838
Diabetologia. 2000 Jul;43(7):915-21
pubmed: 10952465
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
J Diabetes Investig. 2017 May;8(3):369-376
pubmed: 27736033
PLoS One. 2013;8(3):e58783
pubmed: 23533591
Arch Med Sci. 2016 Apr 1;12(2):390-3
pubmed: 27186185
J Clin Neurophysiol. 2009 Oct;26(5):372-9
pubmed: 19752742
Muscle Nerve. 2003 Feb;27(2):202-10
pubmed: 12548528
J Diabetes Investig. 2018 Sep;9(5):1173-1181
pubmed: 29430866
PLoS One. 2014 Jan 22;9(1):e86515
pubmed: 24466129
Muscle Nerve. 2010 Aug;42(2):157-64
pubmed: 20658599
Diabetes Care. 2006 Sep;29(9):2023-7
pubmed: 16936147
J Neurol. 1998 Feb;245(2):81-6
pubmed: 9507412
Front Endocrinol (Lausanne). 2017 Aug 15;8:203
pubmed: 28861044
J Diabetes Investig. 2017 Sep;8(5):646-655
pubmed: 28267267